Thomas Buser

Thomas Buser, a prominent inventor based in Nuglar, Switzerland, has made significant strides in the pharmaceutical industry with a total of 18 patents to his name. His work primarily focuses on modified release drug formulations and innovative methods for producing pharmaceutical products.

Latest Patents

One of Buser's latest innovations includes a patent for a coatable core for a modified release drug formulation. This invention describes a method of producing a high drug load coatable core for oral administration, ensuring that at least 70 wt% of the total weight comprises the drug. The method involves granulating a drug and binder composition, blending it with a pharmacologically acceptable disintegrant, and compressing this blend using an external lubrication compression technique. Another significant patent is related to modified release coated capsules, where Buser details a process to develop capsules that control the release of medications, enhancing therapeutic efficacy.

Career Highlights

Buser has contributed to the field through his work with notable companies like Tillotts Pharma AG and Chrysalis Pharma AG. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in pharmaceutical innovation.

Collaborations

In his journey, Buser has collaborated with other professionals in the field, including Abdul Waseh Basit and Ana Cristina Freire. These collaborations have likely fostered a productive exchange of ideas, leading to further advancements in drug formulation techniques and product development.

Conclusion

Thomas Buser’s contributions to the pharmaceutical industry through his patents and innovative methods are noteworthy. With his continued efforts in drug formulation, he is poised to make a lasting impact on how medications are developed and administered, ultimately benefiting patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.